First patient dosed in Phase III clinical trial for PET radiopharmaceutical Next stage clinical study also proceeding for SPECT radiopharmaceutical Both imaging agents aim to assist in the evaluation ...
Three studies of the human dopamine transporter reveal how it binds to molecules such as dopamine and cocaine. Dopamine imbalances underlie some brain conditions and these data will aid targeted drug ...
Hosted on MSN
Fixing the leak: Blocking an opioid receptor for safer treatment of dopamine-related disorders
Dopamine signaling in the brain is a complex process, with many mechanisms in place to accelerate or slow down dopamine's effects. When dopamine is released from nerve cells, its efficient removal to ...
TEXAS (KIAH) – Nearly one million people in the U.S. are living with Parkinson’s disease (PD). More than 52,000 are Texans. Parkinson’s is the second-most common neurodegenerative disease after ...
We do know Parkinson's is caused by the loss of dopamine nerve cells in the part of the brain responsible for voluntary ...
Dopamine brings on a surge of pleasure, but too much dopamine in a synapse can ultimately lead to mood disorders and addiction. A recent preclinical study published in The FASEB Journal suggests that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback